It has been a wonderful year at the Galen Institute, and we would like to thank all of our supporters for their trust, commitment, and hard work.

We are proud of what we have achieved together, and we hope that our journey has been as fulfilling for you as it has been for us.

What We Have Accomplished

Over the past year, we have made significant progress in advancing our mission of promoting market-based solutions in healthcare. Here are a few highlights:.

1. Healthcare Price Transparency

We have been strong advocates for healthcare price transparency, and we are pleased to see that our efforts have borne fruit.

The Trump Administration has issued a rule that requires hospitals to disclose the prices they negotiate with insurers for a list of 300 common services. This is a major step forward in empowering patients with the information they need to make informed decisions about their healthcare.

2. Association Health Plans

We have also been instrumental in the promotion of Association Health Plans (AHPs).

AHPs allow small businesses and self-employed individuals to band together to purchase healthcare coverage that is more affordable and flexible than what is currently available on the individual and small group markets. We are happy to report that AHPs are now allowed under federal law, thanks in part to our efforts.

3. Medicaid Reform

We believe that Medicaid reform is essential to ensuring that the program is sustainable for future generations.

We have worked tirelessly to promote the use of block grants and per capita caps to provide states with more flexibility and encourage innovation in healthcare delivery. We are pleased to see that our efforts have been recognized by policymakers, and we look forward to continuing the conversation about Medicaid reform in the months to come.

4. Prescription Drug Prices

The high cost of prescription drugs is a major concern for patients and policymakers alike. We believe that the key to lowering drug prices is to increase competition in the marketplace.

We have advocated for policies that would streamline the drug approval process, allow for the importation of safe and affordable drugs from other countries, and encourage the use of biosimilars. We believe that these policies would help to bring down drug costs and improve access to life-saving medications.

Related Article The End of the Galen Institute Offer: A Year in Review

5. The Future of Healthcare

We are excited about the future of healthcare and the potential for innovation to drive down costs and improve outcomes.

We believe that market-based solutions will play a key role in shaping the healthcare landscape in the years to come, and we are committed to promoting policies that support choice, competition, and consumer empowerment.

The End of Our Offer

As our year together comes to a close, we want to remind our supporters that our special offer will soon expire. For those who missed it, we offered a complimentary healthcare policy analysis to the first 100 people who signed up for our newsletter.

This offer was designed to help people better understand their healthcare options and make informed decisions about their coverage.

We are happy to report that all 100 slots have been filled, and we have received overwhelmingly positive feedback about the analysis.

We are proud to have helped so many people navigate the complicated world of healthcare, and we hope that our insights have been useful.

Looking Ahead

As we look ahead to the coming year, we are excited about the opportunities that lie ahead.

We will continue to advocate for policies that promote market-based solutions in healthcare, and we will continue to educate consumers about their healthcare options. We believe that the future of healthcare is bright, and we are grateful to have so many dedicated supporters who share our vision.

Conclusion

In closing, we want to thank each and every one of our supporters for their dedication to our mission. We could not have achieved so much this year without your help, and we look forward to continuing to work together in the years to come.

Once again, thank you for your commitment to improving healthcare in America.